3,4,5-tricaffeoylquinic acid inhibits the lipopolysaccharide-stimulated production of inflammatory mediators in keratinocytes

Pharmacology

Volumn 90, Issue 3-4, 2012, Pages 183-192

  Lee, Seon Ae ^a   Jung, Eun Byul ^a   Lee, Seon Hwa ^a   Kim, Yun Jeong ^a   Bang, Hyoweon ^a   Seo, Seong Jun ^b   Choi, Young Wook ^a   Kim, Manh Heun ^a   Lee, Min Won ^a   Lee, Chung Soo ^a  

^a Chung Ang University   (South Korea)

^b Chung Ang University   (South Korea)

Author keywords

3,4,5 Tricaffeoylquinic acid; Akt and ERK pathways; Inflammatory mediator production; Keratinocytes; NF B

Indexed keywords

3,4,5 TRICAFFEOYLQUINIC ACID; ANTIINFLAMMATORY AGENT; CAFFEOYL; CHEMOKINE; CYTOKINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 8; LIPOPOLYSACCHARIDE; MITOGEN ACTIVATED PROTEIN KINASE; PLANT MEDICINAL PRODUCT; PROTEIN KINASE B; TOLL LIKE RECEPTOR 4; UNCLASSIFIED DRUG;

ARTICLE; CELL VIABILITY; CYTOKINE PRODUCTION; DERMATITIS; DRUG EFFECT; DRUG ISOLATION; DRUG STRUCTURE; ENZYME ACTIVATION; HUMAN; HUMAN CELL; KERATINOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

CELL SURVIVAL; CELLS, CULTURED; CHLOROGENIC ACID; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; HUMANS; INFLAMMATION MEDIATORS; KERATINOCYTES; LIPOPOLYSACCHARIDES; NF-KAPPA B; PROTO-ONCOGENE PROTEINS C-AKT;

EID: 84865584801     PISSN: 00317012     EISSN: 14230313     Source Type: Journal    
DOI: 10.1159/000342127     Document Type: Article

References (28)

1. Boguniewicz M, Leung DYM: Atopic d ermatitis. J Allergy Clin Immunol 2006;17: S475-S480.
2. Pastore S, Mascia F, Girolomoni G: The contribution of keratinocytes to the pathogenesis of atopic dermatitis. Eur J Dermatol 2006;16: 125-131.
3. Tsuruta D: NF-κB links keratinocytes and lymphocytes in the pathogenesis of psoriasis. Recent Pat Inflamm Allergy Drug Discov 2009;3:40-48.
4. Baker BS: The role of microorganisms in atopic dermatitis. Clin Exp Immunol 2006;144: 1-9.
5. Kang SS, Kauls LS, Gaspari AA: Toll-like receptors: applications to dermatologic disease. J Am Acad Dermatol 2006;54:951-983.
6. Begon E, Michel L, Flageul B, Beaudoil I, Jean-Louis F, Bachelez H, Dubertret L, Musette P: Expression, subcellular localization and cytokinic modulation of Toll-like receptors (TLRs) in normal human keratinocytes: TLR2 up-regulation in psoriatic skin. Eur J Dermatol 2007;17:497-506.
7. Song PI, Park YM, Abraham T, Harten B, Zivony A, Neparidze N, Armstrong CA, Ansel JC: Human keratinocytes express functional CD14 and toll-like receptor 4. J Invest Dermatol 2002;119:424-432.
8. Takeda K, Akira S: Toll-like receptors in innate immunity. Int Immunol 2005;17:1-14.
9. Hsu HY, Wen MH: Lipopolysaccharidemediated reactive oxygen species and signal transduction in the regulation of interleukin-gene expression. J Biol Chem 2002;277: 22131-22139.
10. Jang SI, Kim HJ, Kim YJ, Jeong SI, You YO: Tanshinone IIA inhibits LPS-induced NF-κB activation in RAW 264.7 cells: possible involvement of the NIK-IKK, ERK1/2, p38 and JNK pathways. Eur J Pharmacol 2006;542: 1-7.
11. Ghosh S, Hayden MS: New regulators of NF-κB in inflammation. Nat Rev Immunol 2008;8:837-848.
12. Kim SS, Park RY, Jeon HJ, Kwon YS, Chun W: Neuroprotective effects of 3,5-dicaffeoylquinic acid on hydrogen peroxide-induced cell death in SH-SY5Y cells. Phytother Res 2005;19:243-245.
13. Park KH, Park M, Choi SE, Jeong MS, Kwon JH, Oh MH, Seo SJ, Lee MW: The antioxidative and anti-inflammatory effects of caffeoyl derivatives from the roots of Aconitum koreanum R. Raymond. Biol Pham Bull 2009;32: 2029-2033.
14. Dos Santos MD, Chen G, Almeida MC, Soares DM, de Souza GE, Lopes NP, Lantz RC: Effects of caffeoylquinic acid derivatives and C-flavonoid from Lychnophora ericoides on in vitro inflammatory mediator production. Nat Prod Commun 2010;5:733-740.
15. Lee CS, Lee SA, Kim YJ, Seo SJ, Lee MW: 3,4,5-Tricaffeoylquinic acid inhibits tumor necrosis factor-α-stimulated production of inflammatory mediators in keratinocytes via suppression of Akt-and NF-κB-pathways. Int Immunopharmacol 2011;11:1715-1723.
16. Schreiber E, Matthias P, Muller MM, Schaffner W: Rapid detection of octamer binding proteins with 'mini-extracts', prepared from a small number of cells. Nucleic Acids Res 1989;17:6419.
17. Mosmann T: Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 1983;65:55-63.
18. Kanda N, Koike S, Watanabe S: IL-17 suppresses TNF-α-induced CCL27 production through induction of COX-2 in human keratinocytes. J Allergy Clin Immunol 2005;116: 1144-1150.
19. Kanda N, Watanabe S: Leukotriene B4 enhances tumour necrosis factor-α-induced CCL27 production in human keratinocytes. Clin Exp Allergy 2007;37:1074-1082.
20. Tak PP, Firestein GS: NF-κB: a key role in inflammatory diseases. J Clin Invest 2001;107: 7-11.
21. Sun XF, Zhang H: NF-κB and NF-κBI polymorphisms in relation to susceptibility of tumour and other diseases. Histol Histopathol 2007;22:1387-1398.
22. Rebholz B, Haase I, Eckelt B, Paxian S, Fliag MJ, Ghoreshi K, Nedopasov SA, Mailhammer R, Debey-Pascher S, Schultz JL, Weindl G, Forster I, Huss R, Stratis A, Ruzicka T, Rocken, Pfeffer K, Schmid RM, Rupec RA: Crosstalk between keratinocytes and adaptive immune cells in an IκB-α proteinmediated inflammatory disease of the skin. Immunity 2007;27:296-307.
23. Angelini F, Di Matteo G, Balestrero S, Brunetti E, Mancino G, Rossi P, Galli E: Nuclear factor-κB activity is increased in peripheral blood mononuclear cells of children affected by atopic and non-atopic eczema. Int J Immunopathol Pharmacol 2007;20:59-67.
24. Young CN, Koepke JI, Terlecky LJ, Borkin MS, Boyd SL, Terlecky SR: Reactive oxygen species in tumor necrosis factor-α-activated primary human keratinocytes: implications for psoriasis and inflammatory skin disease. J Invest Dermatol 2008;128:2606-2614.
25. Kim YI, Lee JW, Lee MH, Park SW, Cho BN, Lee HK: Effects of 15-deoxy-Δ12,14-prostaglandin J2 on the production of IL-8 and the expression of Toll-like receptor-2 in human primary keratinocytes stimulated with lipopolysaccharide. Mol Biol Rep 2011; 38:3207-3212.
26. Henkel T, Machleidt T, Alkalay I, Kronke M, Ben-Neriah Y, Baeuerle PA: Rapid proteolysis of IκB-α is necessary for activation of transcription factor NF-κB. Nature 1993;365: 182-185.
27. Vestergaard C, Johansen C, Otkjaer K, Deleuran M, Iversen L: Tumor necrosis factor-α-induced CTACK/CCL27 (cutaneous T-cell-attracting chemokine) production in keratinocytes is controlled by nuclear factor-κB. Cytokine 2005;29:49-55.
28. Chang F, Steelman LS, Shelton JG, Lee JT, Navolanic PM, Blalock WL, Franklin R, Mc-Cubrey JA: Regulation of cell cycle progression and apoptosis by the Ras/Raf/MEK/ERK pathway. Int J Oncol 2003;22:469-480.